Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships

Renate Spohn1, Ute Buwitt-Beckmann, Roland Brock

  • 1EMC microcollections GmbH, Sindelfinger Street 3, 72070 Tuebingen, Germany. spohn@microcollections.de

Vaccine
|June 15, 2004
PubMed